Bacillus coagulans SNZ-1969 and No Adverse Health Effects

• Safety evaluation of Bacillus coagulans SNZ 1969 in Wistar rats.

  • 2020-02
  • Clinical Trial · n = 6
  • Regulatory Toxicology and Pharmacology 110
  • • A. Metlakunta
    • R. J. Soman

  • PubMed: 31751640
  • DOI: 10.1016/j.yrtph.2019.104538

  3 Insights on

  • No Adverse Health Effects

  • Low evidence
  • Animal Study

  The results of these study indicate that there were no treatment related changes in any of the parameters studied i.e. clinical signs, body weight, food intake, urinalysis, hematological examinations, clinical biochemistry, gross pathology and histopathology after 28 days of repeated administration.

  Effect

  Neutral

  Effect size

  Small

  Significant

  No